Abstract Purpose: Dendritic cells (DCs) are characterized by their extraordinary capacity to
induce T-cell responses, providing the opportunity of DC-based cancer vaccination …

Abstract Background Dendritic cells (DCs) are the professional antigen-presenting cells of
the immune system. As such they are currently used in clinical vaccination protocols in …

Abstract Background Dendritic cells (DCs) are the most effective antigen-presenting cells. In
the last decade, the use of DCs for immunotherapy of cancer patients has been vastly …

Abstract Dendritic cells (DCs), antigen-presenting cells capable of priming naive T cells to
specific antigens in an HLA-restricted fashion, have been demonstrated to induce protective …

Developing a process to generate dendritic cells (DCs) applicable for multicenter trials
would facilitate cancer vaccine development. Moreover, targeting multiple antigens with …

Dendritic cells (DC) are the most potent APC with the unique capacity to initiate primary
immune responses. For clinical use DC can be generated in vitro from CD34+ peripheral …

The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies
on the generation of potent DC capable of presenting tumor antigens such as …

Dendritic cells (DCs) are considered the most effective antigen-presenting cells (APCs) for
primary immune responses. Since presentation of antigens to the immune system by …

Effective antitumor immunity requires the generation and persistence of functional tumor-
specific T-cell responses. Among the critical factors that often control these responses is how …

Background: Dendritic cells (DCs) are the professional antigen-presenting cells of the
immune system. We have demonstrated that vaccination of autologous ex vivo cultured DCs …